Sort by
Medicine and Dentistry
Breast Cancer
100%
Assessment of Humans
100%
Gamma Urogastrone
100%
Epidermal Growth Factor Receptor 2
100%
Diseases
100%
Tumor
20%
Clinical Oncology
15%
Pathologist
15%
Fluorescence in Situ Hybridization
10%
Malignant Neoplasm
5%
Neoplasm
5%
Targeted Therapy
5%
Patient Characteristics
5%
Immunohistochemistry
5%
Trastuzumab
5%
Nursing and Health Professions
Breast Cancer
100%
Epidermal Growth Factor Receptor 2
100%
Assessment of Humans
100%
Gamma Urogastrone
100%
Diseases
100%
Practice Guideline
15%
Pathologist
15%
Fluorescence in Situ Hybridization
10%
Cancer Center
5%
Neoplasm
5%
Immunohistochemistry
5%
Trastuzumab
5%
Keyphrases
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Early Breast Cancer
100%
Direct Therapy
100%
Test Pattern
100%
Tumor
20%
American Society of Clinical Oncology
15%
College of American Pathologists
15%
Fluorescence in Situ Hybridization
10%
Reflex Testing
10%
Discordance Rate
10%
Targeted Therapy
5%
Quality Indicators
5%
Immunohistochemistry
5%
Trastuzumab
5%
Chart Review
5%
Patient Characteristics
5%
Testing Practices
5%
Tumor Registry
5%
Cancer Institute
5%
Clinical Notes
5%
Test Guideline
5%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Gamma Urogastrone
100%
Epidermal Growth Factor Receptor 2
100%
Diseases
100%
Malignant Neoplasm
5%
Neoplasm
5%
Trastuzumab
5%
Neuroscience
Epidermal Growth Factor Receptor 2
100%
Gamma Urogastrone
100%
In Situ Hybridization
10%
Trastuzumab
5%
Immunohistochemistry
5%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
100%
Fluorescence in Situ Hybridization
10%
Human Characteristic
5%
Trastuzumab
5%
Targeted Therapy
5%